SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

Transcripts Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Equities

1349

CNE1000000W4

Delayed Hong Kong S.E. Other stock markets 03:15:55 2024-05-22 am EDT			5-day change	1st Jan Change
2.18 ^HKD	-0.46%		-1.80%	-14.51%

Apr. 29	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 22	Shanghai Fudan-Zhangjiang Buys Structured Deposits Worth 200 Million Yuan	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Announces Supplemental Announcement Related to Earnings Guidance for the Six Months Ended 30 June 2022	22-08-24	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022	22-08-15	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Earnings Guidance for the Year Ended December 31, 2019	20-01-31	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2019	19-07-18	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Provides Unaudited Consolidated Earnings Guidance for the Year Ended December 31, 2018	19-01-21	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2017	18-01-23	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Provides Earnings Guidance for the 31 December 2013	14-02-10	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Provides Earnings Guidance for the Year Ended December 31, 2012	13-01-31	CI
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Provides Group Earnings Guidance for the Year Ended December 31, 2011	12-02-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW